Pregabalin Capsule 50 mg (Pregabalin)

Adult dose

This medication as pregabalin is administered orally in two divided doses without regard to meals. 1. Neuropathic pain - Peripheral neuropathic pain: Starting dose is 150 mg per day, which can be increased to 300 mg per day after 3 to 7 days, and if needed, can be increased to a maximum of 600 mg at 7-day intervals. - Central neuropathic pain: Starting dose is 150 mg per day, which can be increased to 300 mg per day after one week.

Child dose

Administration to children under 12 years old and adolescents aged 12 to 17 is not recommended due to insufficient safety and efficacy data.

This medication may increase the risk of suicidal thoughts and behaviors, so patients should immediately inform their healthcare provider if they experience mood changes or depression symptoms while taking it. Patients with allergies to this drug's components should not take it. Diabetic patients may need to adjust the dosage of their blood sugar control medications due to weight gain. In case of severe allergic reactions such as angioedema, the medication should be discontinued immediately, and medical advice should be sought. Elderly patients may experience dizziness or drowsiness while taking this medication, so caution is needed to avoid the risk of falls and accidents. This drug may cause temporary blurred vision or changes in vision, and patients should consult their healthcare provider if they experience these symptoms. Withdrawal symptoms such as insomnia, headache, and anxiety may occur upon discontinuation, so the dosage should be gradually reduced as per doctor’s instruction. Patients with a history of drug abuse may have a higher risk of abuse with this medication, and caution is needed during its use. Patients with reduced kidney function may require dosage adjustments. Patients with severe heart conditions should exercise caution when taking this medication, and if symptoms of heart failure occur, they should consult their healthcare provider immediately. Caution should be exercised when taking this drug in combination with other medications that have central nervous system depressant effects due to the risk of respiratory depression. Pregnant women should avoid this medication due to the risk of fetal malformations in early pregnancy, and women of childbearing age should use effective contraception. Breastfeeding women are advised to stop nursing or discontinue this medication as it can be passed into breast milk. Activities requiring attention, such as driving or operating machinery, should be avoided until dizziness or drowsiness subsides after taking this medication. In case of overdose, symptoms such as confusion, drowsiness, and seizures may occur, and immediate emergency treatment should be sought. This medication should be kept out of reach of children, and transferring it to another container could pose an accident risk.

Serious side effects

Hives, severe swelling (angioedema), chest tightness, difficulty breathing, cold sweat, paleness, severe rash with fever, blisters, skin peeling, pain in mucous membranes of the mouth/eyes, shortness of breath or difficulty breathing, asthma attacks, respiratory abnormalities accompanied by cough and fever, jaundice (yellowing of skin or eyes), significant lethargy, sudden and severe headaches, thunderclap headaches, seizures, altered consciousness, visual disturbances, paralysis

Mild side effects

• Dizziness
• drowsiness
• confusion
• spatial disorientation
• irritability
• depression
• euphoria
• decreased libido
• insomnia
• derealization

This medication should be stored in a tightly closed container to prevent exposure to air or moisture, and it is best to keep it at room temperature between 15 to 30 degrees Celsius.

Appearance

Hard capsule consisting of a dark blue upper part and a white lower part filled with white or grayish-white crystalline powder

Package unit

30 capsules/bottle